Interv Akut Kardiol. 2016;15(3):145-147 | DOI: 10.36290/kar.2016.029

Cardiac amyloidosis: a case report

František Kováčik, Miloš Táborský, Martin Hutyra, Ondřej Moravec, Jan Přeček
I. interní klinika &ndash, kardiologická, Fakultní nemocnice Olomouc

This case report describes cardiac symptoms as a dominating feature in the clinical picture of newly diagnosed systemic AL

amyloidosis. The definitive diagnosis was confirmed microscopically following endomyocardial biopsy. Subsequently, systemic

chemotherapy was initiated as the basic treatment for systemic AL amyloidosis.

Keywords: cardiac amyloidosis, cardiac symptoms, treatment for systemic AL amyloidosis

Published: October 1, 2016  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Kováčik F, Táborský M, Hutyra M, Moravec O, Přeček J. Cardiac amyloidosis: a case report. Interv Akut Kardiol. 2016;15(3):145-147. doi: 10.36290/kar.2016.029.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Vojáček J, Kettner J. Klinická kardiologie 2. Vydání, 2012: 493-495.
    2. Kyle RA, Gertz MA. Primary systemic amyloidosis: clinical and laboratory features in 474 cases. Semin Hematol. 1995; 32: 45-59.
    3. Kristen AV, Dengler TJ, Hegenbart U, Schonland SO, Goldschmidt H, Sack FU, Voss F, Becker R, Katus HA, Bauer A. Prophylactic implantation of cardioverter-defibrillator in patients with severe cardiac amyloidosis and high risk for sudden cardiac death, Heart Rhythm 2008; 5: 235-240. Go to original source... Go to PubMed...
    4. Adam Z, Krejčí M, Vorlíček J, a kolektiv. Hematologie - Přehled maligních hematologických nemocí, 2008; 254-255.
    5. Raymond Y, Kwong MD, Rodney H, Falk MD. Cardiovascular Magnetic Resonance in Cardiac Amyloidosis, Circulation. 2005; 111: 122-124. Go to original source... Go to PubMed...
    6. Falk RH. Cardiac amyloidosis, Circulation. 2011; 124: 1079-1085. Go to original source... Go to PubMed...
    7. Krejčí J. Heart failure in AL amyloidosis - Are we still helpless? Cor et Vasa, 2013; 55: e330-e332. Go to original source...
    8. Adam Z, Krejčí J, Krejčí M, Němec P, Špinarová L, Žampachová V, Čermáková Z, Pika T, Pour L, Kořístek Z, Tomiška M, Szturz P, Král Z, Mayer J. Transplantace srdce a následná léčba AL amyloidózy. Vnitřní lékařství, Praha: Česká lékařská společnost J. E. Purkyně, 2013; 59(2): 136-147.
    9. Kristen AV, Sack FU, Schonland SO, et al. Staged heart transplantation and chemotherapy as a treatment option in patients with severe cardiac light-chain amyloidosis, European Journal of Heart Failure, 2009; 11: 1014-1020. Go to original source... Go to PubMed...
    10. Sanchorawala V, Wright DG, Seldin DC, et al. High-dose intravenous melphalan and autologous stem cell transplantation as initial therapy or following two cycles of oral chemotherapy for the treatment of AL amyloidosis: result of prospective randomized trial. Bone Marrow Transplant. 2004; 33: 381-388. Go to original source... Go to PubMed...
    11. Falk RH, Dubrey SW. Amyloid heart disease, Progress in Cardiovascular Diseases, 2010; 52: 347-361. Go to original source...

    Return to the content


    Interventional Cardiology

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.